MBL

MBL, or Mycobacterium bovis Bacillus Calmette-Guérin, is a form of immunotherapy used to treat certain bladder cancers. It involves placing a weakened version of the bacteria directly into the bladder, which stimulates the body's immune system to recognize and attack cancer cells. This treatment leverages the body's natural defenses, encouraging an immune response specifically targeted at the tumor. MBL is a localized treatment, meaning it works where it's applied, with limited systemic side effects, and is generally effective for non-muscle invasive bladder cancer.